Guest guest Posted December 2, 2010 Report Share Posted December 2, 2010 I am so nausea it sucksFrom: Gloria <gadamscan@...> Sent: Wed, December 1, 2010 9:01:37 PMSubject: Re: [ ] HCV ESLD SharonJust about everyone that has HepC suffers from these symptoms. You certainly don't have to be anywhere near ESLD..Gloria Fatigue, nausea, headaches and have to go look at it again but I counted 4.From: Theresa Gottlieb <theresagottlieb@...> < >Sent: Wed, December 1, 2010 1:34:38 PMSubject: Re: [ ] HCV Advocate Email Alert Which 4?On Wed, Dec 1, 2010 at 8:54 AM, Sharon Mcdonald <sharonmcdonald95@...> wrote: Don,I looked at the list for ESLD and I have 4 of the symptoms. sharon From: Christ <ludichrist2000@...> 009 - VCHepC <VCHepC >; Hepatitis C <Hepatitis C >; HepCingles2 grp <HepCingles2 >; WebWarriors grp < > Sent: Tue, November 30, 2010 9:03:52 PMSubject: [ ] HCV Advocate Email Alert December 1, 2010 HCV » AASLD 2010 Coverage » HCV Fact Sheets » Educational Materials » HCSP Streaming Videos Hello This week the HCV Advocate Eblast contains the following updated files and information: 1. Newsletter: AASLD 2010 Conference - Part 1Alan Franciscus, Editor-in-Chief This year's AASLD Conference was chock-full of information about the Direct Acting Antivirals (DDAs) being developed to treat hepatitis C - some pretty amazing results. IL28B Gene Highlighted at AASLDLiz Highleyman IL28B is an important variation on a gene that can help predict and guide treatment. There are also pitfalls to using this test, but big questions remains as to how this information will apply to the new DAAs. HealthWise: 2010 Liver Meeting UpdateLucinda Porter, RN Lucinda provides her unique perspective on this year's AASLD Conference. HCV SnapshotsLucinda Porter, RN Lucinda discusses various studies such as pain management in the cirrhotic patient, treatment in people with recurrence of HCV after transplantation and the affect of alcohol on the liver. 2. Redesigned Drug Pipeline Check out our newly designed and hopefully easier to access HCV Drug Pipeline. We would be interested in your opinion of the new design and ease of access. Send your email to alanfranciscus@... 3. HBV Journal Review This month's journal has extended coverage on the risks of breastfeeding and antiviral use in mother-to-child HBV transmission. 4. "Disability & Benefits: Rumors, Myths, and a Little Truth" Get the skinny on the myths surrounding Disability in Jacques Chamber's monthly column. 5. Top 10 HCV Downloads and HBV Downloads of the Month Find out about the articles and factsheets others are reading-from disability issues to treatment side effect management. Sincerely,Alan Join me on Twitter - . Alan Franciscus Executive Director, Hepatitis C Support Project Editor-in-Chief, HCV Advocate www.hcvadvocate.org Editor-in-Chief, HBV Advocate www.hbvadvocate.org . **Questions and Comments: Questions and/or comments can be directed to alanfranciscus@... Make sure that your email address is all lower case. . HBV » HBV Factsheets » HBV & HCV Advocate Hepatitis Blog » Stay connected with all the late-breaking news on hepatitis B-Join us on Twitter Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 2, 2010 Report Share Posted December 2, 2010 Get Some Pickled Ginger, like the kind you get with sushi. It will help with the nasuia. At 07:21 AM 12/2/2010, you wrote: > > >I am so nausea it sucks > > >From: Gloria <gadamscan@...> > >Sent: Wed, December 1, 2010 9:01:37 PM >Subject: Re: [ ] HCV ESLD > > > >Sharon > >Just about everyone that has HepC suffers from >these symptoms. You certainly don't have to be anywhere near ESLD.. > >Gloria > > > > > > >Fatigue, nausea, headaches and have to go look at it again but I counted 4. > >From: Theresa Gottlieb <theresagottlieb@...> > < > >Sent: Wed, December 1, 2010 1:34:38 PM >Subject: Re: [ ] HCV Advocate Email Alert > > > >Which 4? > >On Wed, Dec 1, 2010 at 8:54 AM, Sharon Mcdonald ><<mailto:sharonmcdonald95@...>sharonmcdonald95@...> wrote: > > >Don, > >I looked at the list for ESLD and I have 4 of the symptoms. > >sharon > > >From: Christ ><<mailto:ludichrist2000@...>ludichrist2000@...> >009 - VCHepC ><<mailto:VCHepC >VCHepC >; >Hepatitis C ><<mailto:Hepatitis C >Hepatitis C >; >HepCingles2 grp ><<mailto:HepCingles2 >HepCingles2 >; >WebWarriors grp ><<mailto: > > >Sent: Tue, November 30, 2010 9:03:52 PM >Subject: [ ] HCV Advocate Email Alert > > > > >[] > >December 1, 2010 > > > > HCV >» ><http://www.hcvadvocate.org/news/reports/AASLD%202010/AASLD%202010%20TOC.htm>AA\ SLD >2010 Coverage >» ><http://www.hcvadvocate.org/hepatitis/factsheets.asp>HCV Fact Sheets >» ><http://www.hcvadvocate.org/hepatitis/materials.asp>Educational Materials >» ><http://www.hcvadvocate.org/hepatitis/training_resources.asp>HCSP >Streaming Videos > > >[] > > >Hello > >This week the HCV Advocate Eblast contains the >following updated files and information: > > > ><http://www.hcvadvocate.org/news/newsLetter/2010/advocate1210.html>1. >Newsletter: >AASLD 2010 Conference - Part 1 >Alan Franciscus, Editor-in-Chief >This year's AASLD Conference was chock-full of >information about the Direct Acting Antivirals >(DDAs) being developed to treat hepatitis C - some pretty amazing results. > > >IL28B Gene Highlighted at AASLD >Liz Highleyman >IL28B is an important variation on a gene that >can help predict and guide treatment. There are >also pitfalls to using this test, but big >questions remains as to how this information will apply to the new DAAs. > > >HealthWise: 2010 Liver Meeting Update >Lucinda Porter, RN >Lucinda provides her unique perspective on this year's AASLD Conference. > > >HCV Snapshots >Lucinda Porter, RN >Lucinda discusses various studies such as pain >management in the cirrhotic patient, treatment >in people with recurrence of HCV after >transplantation and the affect of alcohol on the liver. > > > ><http://www.hcvadvocate.org/hepatitis/hepC/HCVDrugs.html>2. >Redesigned Drug Pipeline >Check out our newly designed and hopefully >easier to access HCV Drug Pipeline. We would be >interested in your opinion of the new design and >ease of access. Send your email to ><http://us.mc1301.mail./mc/compose?to=alanfranciscushcvadvocate (DOT) org>a\ lanfranciscus@... > > > ><http://www.hbvadvocate.org/news/HBJ7.12.htm>3. ><http://www.hbvadvocate.org/news/HBJ7.12.htm>HBV Journal Review >This month's journal has extended coverage on >the risks of breastfeeding and antiviral use in >mother-to-child HBV transmission. > > ><http://www.hcvadvocate.org/hepatitis/hepC/Rumors,%20Myths,%20and%20a%20Little%\ 20Truth_10.html>4. > " Disability & Benefits: Rumors, Myths, and a Little Truth " >Get the skinny on the myths surrounding >Disability in Jacques Chamber's monthly column. > > >5. ><http://www.hcvadvocate.org/hepatitis/Top_Dwnloads_Nov24_10.asp>Top >10 HCV Downloads and ><http://www.hbvadvocate.org/hepatitis/B%20top10%20%20Nov24_10.asp>HBV >Downloads of the Month >Find out about the articles and factsheets >others are reading-from disability issues to >treatment side effect management. > > > > >Sincerely, >Alan > > ><http://twitter.com/HCVAdvocate>Join me on Twitter - >. > >Alan Franciscus >Executive Director, Hepatitis C Support Project >Editor-in-Chief, HCV Advocate ><http://www.hcvadvocate.org/>www.hcvadvocate.org >Editor-in-Chief, HBV Advocate ><http://www.hbvadvocate.org/>www.hbvadvocate.org > >. > >**Questions and Comments: Questions and/or >comments can be directed to ><http://us.mc1301.mail./mc/compose?to=alanfranciscushcvadvocate (DOT) org>a\ lanfranciscus@... > > > > >Make sure that your email address is all lower case. > >. > ><http://www.hcvadvocate.org/index.asp> >[] > > HBV >» ><http://www.hbvadvocate.org/hepatitis/factsheets.asp>HBV Factsheets >» ><http://hcvadvocate.blogspot.com/>HBV & HCV Advocate Hepatitis Blog >» ><http://twitter.com/HBVAdvocate>Stay connected >with all the late-breaking news on hepatitis >B<http://twitter.com/HBVAdvocate>-Join us on Twitter > > > > > > > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.